These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 8297920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
    Gallagher P, Watson S, Elizabeth Dye C, Young AH, Nicol Ferrier I.
    J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
    [Abstract] [Full Text] [Related]

  • 3. Antiglucocorticoid therapies in major depression: a review.
    Murphy BE.
    Psychoneuroendocrinology; 1997 Oct; 22 Suppl 1():S125-32. PubMed ID: 9264159
    [Abstract] [Full Text] [Related]

  • 4. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
    Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN.
    Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
    [Abstract] [Full Text] [Related]

  • 5. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR.
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [Abstract] [Full Text] [Related]

  • 6. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH, Dinan TG.
    Biol Psychiatry; 1995 Mar 15; 37(6):364-8. PubMed ID: 7772644
    [Abstract] [Full Text] [Related]

  • 9. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.
    Anand A, Malison R, McDougle CJ, Price LH.
    Biol Psychiatry; 1995 Mar 01; 37(5):338-40. PubMed ID: 7748987
    [No Abstract] [Full Text] [Related]

  • 10. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 01; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 11. Clinical and biological effects of mifepristone treatment for psychotic depression.
    Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF.
    Neuropsychopharmacology; 2006 Mar 01; 31(3):628-36. PubMed ID: 16160710
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction.
    Blasey CM, Debattista C, Roe R, Block T, Belanoff JK.
    Contemp Clin Trials; 2009 Jul 01; 30(4):284-8. PubMed ID: 19318138
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
    Nemeroff CB.
    Hum Psychopharmacol; 2002 Jun 01; 17 Suppl 1():S13-6. PubMed ID: 12404664
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rapid reversal of psychotic depression using mifepristone.
    Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF.
    J Clin Psychopharmacol; 2001 Oct 01; 21(5):516-21. PubMed ID: 11593077
    [Abstract] [Full Text] [Related]

  • 18. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA.
    Int Clin Psychopharmacol; 1997 Mar 01; 12(2):91-7. PubMed ID: 9219044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.